Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Methadone child deaths prompt call for pharmacist and GP training

Substance misuse charity Adfam is calling for co-ordinated national action to better safeguard the children of those on opioid substitution treatments

Pharmacists must learn not to stigmatise methadone-using parents and should help to prevent children from accidentally taking the drug, substance misuse charity Adfam has said.


Children were at risk of ingesting their parent's methadone due to insufficient safeguards and pharmacists needed to be trained to spot these symptoms and explain the risks to patients, the charity said in a report published last week (April 29).


Although supervised consumption was advised when there were concerns about safe storage or risks to children, parents on opioid substitution treatments (OST) often felt ashamed to consume their methadone with their children in a pharmacy due to a lack of privacy, the charity claimed.


Parents complained of a lack of privacy when consuming their methadone in a pharmacy, Adfam's report found

More on addiction services

Demand for NI needle exchange scheme up 60 per cent in four years

Get involved in needle exchange, Nice urges pharmacists

On the front line of addiction


A 2007 study of methadone users in Staffordshire and Shropshire had shown that patients wanted pharmacists to receive training to combat their stigma towards methadone users, the charity said. It was important healthcare professionals were supportive of users that were parents and did not alienate them, it said.


More than 60,000 people caring for children received prescriptions for OST in the UK, Adfam said. There were 20 serious case reviews by local safeguarding children boards into the ingestion of drug addiction medications between 2003 and 2013, 15 of which involved a death involving methadone, Adfam said.


In order to minimise these risks, healthcare professionals must understand the dangers methadone posed to children and other "opioid naive" people, the charity stressed.


It referred to a 2005 study which revealed that 21 per cent of OST users who received information on safe storage of their methadone had received it from a pharmacist, compared to 42 per cent who were advised by a methadone clinic and 27 per cent who spoke to a local drug agency, the charity said.


The same study had shown that prescribing pharmacists were not as good as drug workers at understanding and addressing how medicines should be safeguarded at home. These pharmacists perceived speaking to patients as "risky" and preferred to give "non-confrontational" written information instead, the charity said.


But clinicians should use their first appointment with a patient to emphasise the importance of keeping their methadone safely stored in a locked box, it said.


"Professionals must understand this rationale, and be able to transmit the message to clients in a clear but sensitive way. This can be supported by clear literature and information in drug agencies and pharmacies," it added.


When dispensing methadone, do you give advice on safe storage as a matter of course or do you leave this to the prescribing doctor/clinic?
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel